Literature DB >> 16792475

Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction.

O Joulin1, P Petillot, M Labalette, S Lancel, R Neviere.   

Abstract

This study was designed to measure nitrite/nitrate and cytokine levels of serum obtained from septic shock patients and to describe potential depressant effects of human septic serum on rat cardiomyocytes. Serum was prepared from 10 non-septic patients and 10 patients with documented septic shock. Adult rat ventricular myocytes were exposed to 20 % serum in the medium. Cardiomyocyte contractility was assessed by measuring shortening fraction and shortening velocity. Serum levels of nitrite/nitrate, a marker of nitric oxide final metabolites, and cytokines (tumor necrosis factor (TNF)-alpha, interleukin (IL) 1beta, 6, 10, 8 and 12p70) were measured. Compared with serum from non-septic patients, serum of septic shock patients induced rapid reduction of the extent and velocity of shortening in isolated cardiomyocytes. Nitrite/nitrate, TNF-alpha, IL-1beta and IL-12p70 concentrations of tested serum for cardiomyocyte studies were not increased in septic serum compared with controls. In contrast, septic serum that induced a depression of in vitro contractility, had increased levels of IL-6, IL-8 and IL-10. We can conclude that the depression of in vitro contractility induced by septic serum is not directly dependent on elevated levels of nitric oxide metabolites, TNF-alpha or IL-1beta. Our results support the view that other cytokines, including IL-6, IL-8 and IL-10, are potent circulating mediators of myocardial depression in cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792475

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  16 in total

1.  IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?

Authors:  Oliver Friedrich; Bing Yi; Joshua N Edwards; Barbara Reischl; Anette Wirth-Hücking; Andreas Buttgereit; Roland Lang; Cornelia Weber; Fabian Polyak; Ilon Liu; Frederic von Wegner; Tanya R Cully; Aven Lee; Patrick Most; Mirko Völkers
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

2.  Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II.

Authors:  P Kellner; R Prondzinsky; L Pallmann; S Siegmann; S Unverzagt; H Lemm; S Dietz; J Soukup; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-04-06       Impact factor: 0.840

Review 3.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

4.  Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis.

Authors:  Xiaohong Wang; Wei Huang; Yang Yang; Yigang Wang; Tianqing Peng; Jiang Chang; Charles C Caldwell; Basilia Zingarelli; Guo-Chang Fan
Journal:  Biochim Biophys Acta       Date:  2014-01-29

5.  Complement dependency of cardiomyocyte release of mediators during sepsis.

Authors:  Gelareh Atefi; Firas S Zetoune; Todd J Herron; José Jalife; Markus Bosmann; Rami Al-Aref; J Vidya Sarma; Peter A Ward
Journal:  FASEB J       Date:  2011-04-08       Impact factor: 5.191

6.  Enhanced muscle shortening and impaired Ca2+ channel function in an acute septic myopathy model.

Authors:  Oliver Friedrich; Ernst Hund; Frederic von Wegner
Journal:  J Neurol       Date:  2009-11-04       Impact factor: 4.849

7.  Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Andrew T Yan; Raymond T Yan; Mary Cushman; Alban Redheuil; Russell P Tracy; Donna K Arnett; Boaz D Rosen; Robyn L McClelland; David A Bluemke; Joao A C Lima
Journal:  Eur Heart J       Date:  2010-01-10       Impact factor: 29.983

8.  New insights for C5a and C5a receptors in sepsis.

Authors:  Chunguang Yan; Hongwei Gao
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

Review 9.  Role of C5 activation products in sepsis.

Authors:  Peter A Ward
Journal:  ScientificWorldJournal       Date:  2010-12-14

10.  Cardiac stem cells: A promising treatment option for heart failure.

Authors:  Xiaohui Zhao; Lan Huang
Journal:  Exp Ther Med       Date:  2012-12-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.